[Treatment of rheumatoid arthritis in children with tetracosactide beta-24].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D003480:Cushing Syndrome / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D007223:Infant; D007668:Kidney / Q000187:drug effects; D008297:Male; D011605:Psychoses, Substance-Induced / Q000209:etiology
D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone
Die Behandlung der rheumatoiden Arthritis bei Kindern mit Tetracosactid beta'-24.